Bernie Sanders: Ozempic, Wegovy drugmaker is "ripping off" U.S. over weight loss drug cost
![](https://s3-us-west-2.amazonaws.com/adsitepro.com/media/682046/conversions/240412-ozempic-al-1132-4f4f72-large.webp)
Sen. Bernie Sanders says the first question he is going to ask Novo Nordisk's CEO at a committee hearing is why Ozempic and Wegovy costs more in the U.S.
Sen. Bernie Sanders, I-Vt., says the first question he is going to ask Novo Nordisk's CEO at a Senate committee hearing in September is why the drugmaker charges up to 10 or 15 times more for Ozempic and Wegovy in the U.S., compared to other countries.
“This is absurd,” Sanders said in an interview late Tuesday. “It is clear that Novo Nordisk is ripping off the American people.”
Novo Nordisk CEO Lars Fruergaard Jørgensen has agreed to testify in September over the pricing of the drugmaker’s hugely popular weight loss drugs, the Senate Committee on Health, Education, Labor and Pensions announced Friday.
It came three days after Sanders, who chairs the committee, threatened to hold a vote to subpoena Novo Nordisk President Doug Langa to provide testimony.
In a separate statement, a spokesperson for Novo Nordisk said that Jørgensen agreed after he and Sanders had "a productive call and agreed to find a mutually acceptable date for a hearing."
Rating: 5